Cargando…

Neuroprotective Potential of Biflavone Ginkgetin: A Review

Neurological disorders are becoming more common, and there is an intense search for molecules that can help treat them. Several natural components, especially those from the flavonoid group, have shown promising results. Ginkgetin is the first known biflavonoid, a flavonoid dimer isolated from ginkg...

Descripción completa

Detalles Bibliográficos
Autores principales: Tatlı Çankaya, İ. İrem, Devkota, Hari Prasad, Zengin, Gokhan, Šamec, Dunja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964866/
https://www.ncbi.nlm.nih.gov/pubmed/36836918
http://dx.doi.org/10.3390/life13020562
_version_ 1784896614976978944
author Tatlı Çankaya, İ. İrem
Devkota, Hari Prasad
Zengin, Gokhan
Šamec, Dunja
author_facet Tatlı Çankaya, İ. İrem
Devkota, Hari Prasad
Zengin, Gokhan
Šamec, Dunja
author_sort Tatlı Çankaya, İ. İrem
collection PubMed
description Neurological disorders are becoming more common, and there is an intense search for molecules that can help treat them. Several natural components, especially those from the flavonoid group, have shown promising results. Ginkgetin is the first known biflavonoid, a flavonoid dimer isolated from ginkgo (Ginkgo biloba L.). Later, its occurrence was discovered in more than 20 different plant species, most of which are known for their use in traditional medicine. Herein we have summarized the data on the neuroprotective potential of ginkgetin. There is evidence of protection against neuronal damage caused by ischemic strokes, neurotumors, Alzheimer’s disease (AD), and Parkinson’s disease (PD). Beneficial effects in ischemic strokes have been demonstrated in animal studies in which injection of ginkgetin before or after onset of the stoke showed protection from neuronal damage. AD protection has been the most studied to date. Possible mechanisms include inhibition of reactive oxygen species, inhibition of β-secretase, inhibition of Aβ fibril formation, amelioration of inflammation, and antimicrobial activity. Ginkgetin has also shown positive effects on the relief of PD symptoms in animal studies. Most of the available data are from in vitro or in vivo animal studies, where ginkgetin showed promising results, and further clinical studies should be conducted.
format Online
Article
Text
id pubmed-9964866
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99648662023-02-26 Neuroprotective Potential of Biflavone Ginkgetin: A Review Tatlı Çankaya, İ. İrem Devkota, Hari Prasad Zengin, Gokhan Šamec, Dunja Life (Basel) Review Neurological disorders are becoming more common, and there is an intense search for molecules that can help treat them. Several natural components, especially those from the flavonoid group, have shown promising results. Ginkgetin is the first known biflavonoid, a flavonoid dimer isolated from ginkgo (Ginkgo biloba L.). Later, its occurrence was discovered in more than 20 different plant species, most of which are known for their use in traditional medicine. Herein we have summarized the data on the neuroprotective potential of ginkgetin. There is evidence of protection against neuronal damage caused by ischemic strokes, neurotumors, Alzheimer’s disease (AD), and Parkinson’s disease (PD). Beneficial effects in ischemic strokes have been demonstrated in animal studies in which injection of ginkgetin before or after onset of the stoke showed protection from neuronal damage. AD protection has been the most studied to date. Possible mechanisms include inhibition of reactive oxygen species, inhibition of β-secretase, inhibition of Aβ fibril formation, amelioration of inflammation, and antimicrobial activity. Ginkgetin has also shown positive effects on the relief of PD symptoms in animal studies. Most of the available data are from in vitro or in vivo animal studies, where ginkgetin showed promising results, and further clinical studies should be conducted. MDPI 2023-02-16 /pmc/articles/PMC9964866/ /pubmed/36836918 http://dx.doi.org/10.3390/life13020562 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Tatlı Çankaya, İ. İrem
Devkota, Hari Prasad
Zengin, Gokhan
Šamec, Dunja
Neuroprotective Potential of Biflavone Ginkgetin: A Review
title Neuroprotective Potential of Biflavone Ginkgetin: A Review
title_full Neuroprotective Potential of Biflavone Ginkgetin: A Review
title_fullStr Neuroprotective Potential of Biflavone Ginkgetin: A Review
title_full_unstemmed Neuroprotective Potential of Biflavone Ginkgetin: A Review
title_short Neuroprotective Potential of Biflavone Ginkgetin: A Review
title_sort neuroprotective potential of biflavone ginkgetin: a review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964866/
https://www.ncbi.nlm.nih.gov/pubmed/36836918
http://dx.doi.org/10.3390/life13020562
work_keys_str_mv AT tatlıcankayaiirem neuroprotectivepotentialofbiflavoneginkgetinareview
AT devkotahariprasad neuroprotectivepotentialofbiflavoneginkgetinareview
AT zengingokhan neuroprotectivepotentialofbiflavoneginkgetinareview
AT samecdunja neuroprotectivepotentialofbiflavoneginkgetinareview